NSEUpdates8 Jul 2026 · 8 Jul 2026, 10:53 am
Updates
Panacea Biotec Limited · PANACEABIO
✦ AI Summary
Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during June 2026'. The company has confirmed that no shares were dematerialized during the month of June 2026, with a total of 6,11,05,526 shares dematerialized as on June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Panacea Biotec Limited has informed the Exchange regarding 'Details of Shares dematerialized during June 2026'.
Attachments (1)
📄pdf
Download →
PANACEABIO_08072026105259_DematReportForMonth30062026.pdf
View document text
July 07, 2026
The Manager, Listing Department BSE Limited
The National Stock Exchange of India Ltd. Phiroze Jeejeebhoy Towers,
Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001
Bandra (E), Mumbai - 400 051
National Securities Depository Limited Central Depository Services (India) Ltd.
Trade World, 4th Floor, Kamala Mills Marathon Futurex, A-Wing,
Compound, Senapati Bapat Marg, Lower Parel, 25th Floor, NM Joshi Marg,
Mumbai – 400 013 Lower Parel, Mumbai 400 013
Reg.: Details of Shares dematerialized during June 2026
Ref.: Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Dear Sir,
This is with reference to CDSL’s Operating Instructions for Issuers / RTAs, which states that the Issuer
/ RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the
securities are listed. Accordingly, we would like to inform you that no share has been dematerialized
during the month of June 2026.
We would also like to confirm that the total number of shares dematerialized as on June 30, 2026, were
as under:
NSDL 5,24,78,317
CDSL 86,27,209
Total 6,11,05,526
A copy of the certificate obtained from the Company’s RTA viz. Skyline Financial Services Pvt. Ltd.,
regarding shares dematerialized as on June 30, 2026, is also enclosed as Annexure -1.
This is for your information and record please. Kindly acknowledge the receipt.
Thanking you,
Sincerely yours,
For Panacea Biotec Limited
Ankit Jain
General Manager – Legal & Company Secretary
Encl.: As above
Panacea Biotec Ltd (CIN: L33117PB1984PLC022350)
Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab
Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India
Ph.: 91-11-4167 9000, 4167 8000, Email: companysec@panaceabiotec.com
Skyline Financial Services Pvt. Ltd
S.E.B.I. REGISTERED CATEGORY-1 REGISTRARS & SHARE TRANSFER AGENT
Office :D/153A, 1st Floor, Okhla Industrial Area, Phase – I, New Delhi – 110 020..
Tel. : +91-11-40450195/Fax +91-11-26812682 | CIN :U74899DL1995PTC071324
Email : info@skylinerta.com : website : www.skylinerta.com
July 06,2026 INE922B01023
THE COMPANY SECRETARY
PANACEA BIOTEC LIMITED
B-1 EXTN A-27 MOHAN CO-OPERATIVE
INDUSTRIAL ESTAT MATHURA ROAD
BADARPUR NEW DELHI 110044
DEAR SIR/MADAM,
THE DEMAT STATUS REPORT OF YOUR COMPANY IS AS GIVEN BELOW:
AS ON AS ON CHANGE IN
30/05/2026 30/06/2026 TOTAL
NSDL 53904650 52478317
CDSL 7200876 8627209
---------------------------------------------
TOTAL 61105526 61105526 0
--------------------------------------------